Celularity Inc (CELU) stock
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.48−0.09 (-15.41%)
Close on Nov 18, 2026Market cap $15.68MP/E –Yield –
Celularity net income
Net income is the profit left for shareholders after every expense, interest and tax.
Celularity's net income for the twelve months ending Jun 30, 2026 was -$45.86M. For fiscal 2025 it was -$91.72M. The highest annual figure on record is $14.19M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$91.72M | – |
| FY2024 | Dec 31, 2024 | -$57.89M | – |
| FY2023 | Dec 31, 2023 | -$196.30M | -1483.1% |
| FY2022 | Dec 31, 2022 | $14.19M | – |
| FY2021 | Dec 31, 2021 | -$100.12M | – |
| FY2020 | Dec 31, 2020 | -$208.23M | -3642.1% |
| FY2019 | Dec 31, 2019 | $5.88M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $706.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $874.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$24.36M | – |
| Q3 FY2025 | Sep 30, 2025 | -$23.08M | – |
| Q2 FY2025 | Jun 30, 2025 | -$24.52M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.75M | – |
| Q4 FY2024 | Dec 31, 2024 | -$13.29M | -239.2% |
| Q3 FY2024 | Sep 30, 2024 | -$16.10M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.49M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.01M | – |
| Q4 FY2023 | Dec 31, 2023 | $9.55M | -60.9% |
| Q3 FY2023 | Sep 30, 2023 | -$93.88M | -2056.2% |
| Q2 FY2023 | Jun 30, 2023 | -$47.95M | -200.3% |
| Q1 FY2023 | Mar 31, 2023 | -$64.02M | – |
| Q4 FY2022 | Dec 31, 2022 | $24.43M | – |
| Q3 FY2022 | Sep 30, 2022 | $4.80M | -90.4% |
| Q2 FY2022 | Jun 30, 2022 | $47.83M | – |
| Q1 FY2022 | Mar 31, 2022 | -$62.87M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.04M | -203.3% |
| Q3 FY2021 | Sep 30, 2021 | $49.94M | – |
| Q2 FY2021 | Jun 30, 2021 | -$64.48M | – |
| Q1 FY2021 | Mar 31, 2021 | -$81.54M | -1380.4% |
| Q4 FY2020 | Dec 31, 2020 | $3.91M | -5.2% |
| Q3 FY2020 | Sep 30, 2020 | -$46.33M | -4231.9% |
| Q2 FY2020 | Jun 30, 2020 | -$12.11M | -2008.1% |
| Q1 FY2020 | Mar 31, 2020 | $6.37M | – |
| Q4 FY2019 | Dec 31, 2019 | $4.12M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.12M | – |
| Q2 FY2019 | Jun 30, 2019 | $634.66K | – |
| Q1 FY2019 | Mar 31, 2019 | -$121 | – |
See a number that looks wrong?